Filing Details
- Accession Number:
- 0001213900-18-014061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-17 20:09:48
- Reporting Period:
- 2018-10-17
- Accepted Time:
- 2018-10-17 20:09:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
812796 | Soligenix Inc. | SNGX | Pharmaceutical Preparations (2834) | 411505029 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1486558 | E. Mark Pearson | 29 Emmons Drive, Suite B-10 Princeton NJ 08540 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-10-17 | 170,000 | $1.16 | 2,500,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $1.14 to $1.19. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.